Dapivirine vaginal ring forHIVprevention: modelling health outcomes, drug resistance and cost‐effectiveness-Reference-Cited by-同舟云学术

Dapivirine vaginal ring forHIVprevention: modelling health outcomes, drug resistance and cost‐effectiveness

Published:2019-05 Issue:5 Volume:22 Page:e25282
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Glaubius Robert¹^ORCID,Ding Yajun²,Penrose Kerri J³,Hood Greg⁴,Engquist Erik⁵,Mellors John W³,Parikh Urvi M³^ORCID,Abbas Ume L¹²^ORCID

Affiliation:

1. Departments of Quantitative Health Sciences and Infectious Disease Cleveland Clinic Cleveland OH USA

2. Department of Medicine Section of Infectious Diseases and Department of Molecular Virology and Microbiology Baylor College of Medicine Houston TX USA

3. Division of Infectious Diseases School of Medicine University of Pittsburgh Pittsburgh PA USA

4. Pittsburgh Supercomputing Center Carnegie Mellon University Pittsburgh PA USA

5. Center for Research Computing Rice University Houston TX USA

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25282

Reference62 articles.

1. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

2. Medicines Control Council.Press release: Medicines Control Council approves fixed‐dose combination of tenofovir disoproxyl fumarate and emtricitabine for pre‐exposure prophylaxis of HIV.2015[cited 2017 Jul 3]. Available from:http://www.mccza.com/documents/2e4b3a5310.11_Media_release_ARV_FDC_PrEP_Nov15_v1.pdf

3. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simple calculations of direct impact for the initial assessment of the value of primary HIV prevention interventions;2024-07-14

2. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

3. “It’s already in your body and it’s preventing”: a qualitative study of African female adolescent’s acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa;BMC Public Health;2023-11-02

4. Implementation of HIV prevention strategies globally;The Lancet HIV;2023-08

5. Implementation and resource needs for long‐acting PrEP in low‐ and middle‐income countries: a scoping review;Journal of the International AIDS Society;2023-07